Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
4927.06%
operating margin TTM
5034.09%
revenue TTM
1.59 Million
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -2.75 |
| peg ratio | -0.15 |
| price to book ratio | 4.91 |
| price to sales ratio | -109.36 |
| enterprise value multiple | -1.38 |
| price fair value | 4.91 |
profitability ratios | |
|---|---|
| gross profit margin | 167.51% |
| operating profit margin | 5034.09% |
| pretax profit margin | 4943.42% |
| net profit margin | 4927.06% |
| return on assets | -51.71% |
| return on equity | -151.81% |
| return on capital employed | -56.42% |
liquidity ratio | |
|---|---|
| current ratio | 15.40 |
| quick ratio | 15.40 |
| cash ratio | 2.43 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | -861.20 |
| days of payables outstanding | 1,015.90 |
| cash conversion cycle | -1,877.09 |
| receivables turnover | -0.42 |
| payables turnover | 0.36 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.65 |
| debt equity ratio | 2.25 |
| long term debt to capitalization | 0.69 |
| total debt to capitalization | 0.69 |
| interest coverage | -12.42 |
| cash flow to debt ratio | -0.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.47 |
| cash per share | 1.15 |
| operating cash flow per share | -0.47 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.58 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -765.67 |
Frequently Asked Questions
When was the last time Milestone Pharmaceuticals Inc. (NASDAQ:MIST) reported earnings?
Milestone Pharmaceuticals Inc. (MIST) published its most recent earnings results on 12-11-2024.
What is Milestone Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Milestone Pharmaceuticals Inc. (NASDAQ:MIST)'s trailing twelve months ROE is -151.81%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Milestone Pharmaceuticals Inc. (MIST) currently has a ROA of -51.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MIST's net profit margin stand at?
MIST reported a profit margin of 4927.06% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MIST's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 15.40 in the most recent quarter. The quick ratio stood at 15.40, with a Debt/Eq ratio of 2.25.